This section details the objectives and indicators that will be used to monitor progress. Indicators are measurable targets that apply to the related objective.

The primary indicators are those that have been agreed under the National Healthcare Agreement. These have been specified and will be regularly reported on during the life of the agreement. Additional indicators have been included for the more specific objectives relevant to this strategy. Further work will be undertaken during the implementation phase to develop a surveillance and monitoring plan. This will include further work on specifications for the indicators, and development of an agreed process for reporting on them. In some circumstances further data development may also be needed.

GOALOBJECTIVEINDICATIOR (1)
To reduce the transmission of, and morbidity and mortality caused by, STIs and BBVs, and to minimise the personal and social impact of these infections in Aboriginal and Torres Strait Islander communities.Reduce hepatitis B infectionsCoverage of hepatitis B vaccination among Aboriginal and Torres Strait Islander children and adolescents (Essential Vaccines National Partnership Agreement)
Work towards eliminating infectious syphilis in Aboriginal and Torres Strait Islander peoples.Incidence of infectious syphilis in Aboriginal and Torres Strait Islander peoples (National Healthcare Agreement)
Decrease the proportion of HIV and hepatitis C infections caused by injecting drug useProportion of newly diagnosed HIV and newly diagnosed hepatitis C infection caused by injecting drug use in Aboriginal and Torres Strait Islander peoples
To reduce the transmission of, and morbidity and mortality caused by, STIs and BBVs, and to minimise the personal and social impact of these infections in Aboriginal and Torres Strait Islander communities. Increase the level of systematic testing and treatment of sexually active 15 to 30–year–olds, noting that testing will likely increase the notifications of bacterial STIs in the short term—before a reduction in the long term Proportion of young Aboriginal and Torres Strait Islander peoples who report having had an STI test in the previous 12 months

Proportion of Aboriginal and Torres Strait Islander young people receiving a chlamydia and gonorrhoea test in the previous 12 months
Improve Aboriginal and Torres Strait Islander young people’s knowledge of STIs and BBVs Proportion of Aboriginal and Torres Strait Islander peoples giving correct answers to knowledge questions on STIs and BBVs
Increase the number of Aboriginal and Torres Strait Islander peoples receiving treatment for HIV, hepatitis C and hepatitis B Proportion of Aboriginal and Torres Strait Islander peoples with HIV receiving antiretroviral treatment

Proportion of Aboriginal and Torres Strait Islander peoples with chronic hepatitis C who are dispensed drugs for hepatitis C infection through the Highly Specialised Drugs

Program in the previous 12 months Proportion of Aboriginal and Torres Strait Islander peoples with chronic hepatitis B who are dispensed drugs for hepatitis B infection through the Highly Specialised Drugs Program in the previous 12 months
To reduce the transmission of, and morbidity and mortality caused by, STIs and BBVs, and to minimise the personal and social impact of these infections in Aboriginal and Torres Strait Islander communities. Implement a national accreditation scheme for Aboriginal and Torres Strait Islander sexual health workers, under COAG’s National Registration Program Number of Aboriginal and Torres Strait Islander peoples registered under the National Registration Program
(1) In areas where data are available